$EXPO
EXPONENT INC

2024 Q2 Form 10-Q Financial Statement

#000095017024052966 Filed on May 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $140.5M $144.9M
YoY Change 0.22% 3.3%
Cost Of Revenue $8.102M $7.726M
YoY Change 22.07% -33.42%
Gross Profit $132.4M $137.2M
YoY Change -0.86% 6.61%
Gross Profit Margin 94.23% 94.67%
Selling, General & Admin $87.90M $95.96M
YoY Change -5.9% 6.6%
% of Gross Profit 66.37% 69.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.486M $2.324M
YoY Change 13.72% 16.9%
% of Gross Profit 1.88% 1.69%
Operating Expenses $104.8M $106.5M
YoY Change 1.04% -4.22%
Operating Profit $35.74M $30.71M
YoY Change 19.65% 5.47%
Interest Expense $2.231M $2.626M
YoY Change 40.05% 48.36%
% of Operating Profit 6.24% 8.55%
Other Income/Expense, Net $3.938M $7.084M
YoY Change -17.7% 10.38%
Pretax Income $39.68M $40.42M
YoY Change 9.46% 13.75%
Income Tax $10.46M $10.28M
% Of Pretax Income 26.35% 25.43%
Net Earnings $29.23M $30.14M
YoY Change 13.51% 3.5%
Net Earnings / Revenue 20.8% 20.8%
Basic Earnings Per Share $0.57 $0.59
Diluted Earnings Per Share $0.57 $0.59
COMMON SHARES
Basic Shares Outstanding 50.67M 50.56M
Diluted Shares Outstanding 51.52M 51.42M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $203.3M $168.7M
YoY Change 37.18% 34.24%
Cash & Equivalents $203.3M $168.7M
Short-Term Investments
Other Short-Term Assets $22.20M $20.77M
YoY Change 7.62% 6.05%
Inventory
Prepaid Expenses
Receivables $165.9M $162.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $391.3M $352.3M
YoY Change 13.55% 10.69%
LONG-TERM ASSETS
Property, Plant & Equipment $73.03M $74.50M
YoY Change -4.91% 7.33%
Goodwill $8.607M $8.607M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.807M $3.759M
YoY Change 190.77% 62.59%
Total Long-Term Assets $317.9M $277.1M
YoY Change 22.41% 11.67%
TOTAL ASSETS
Total Short-Term Assets $391.3M $352.3M
Total Long-Term Assets $317.9M $277.1M
Total Assets $709.2M $629.4M
YoY Change 17.36% 11.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.42M $23.93M
YoY Change 13.01% -9.1%
Accrued Expenses $95.63M $74.10M
YoY Change 2.43% 8.51%
Deferred Revenue $13.78M $16.11M
YoY Change 21.44% 10.56%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $131.8M $114.1M
YoY Change 5.85% 4.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.159M $3.580M
YoY Change 60.67% 42.46%
Total Long-Term Liabilities $5.159M $3.580M
YoY Change 60.67% 42.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $131.8M $114.1M
Total Long-Term Liabilities $5.159M $3.580M
Total Liabilities $316.0M $255.1M
YoY Change 27.81% 13.59%
SHAREHOLDERS EQUITY
Retained Earnings $603.4M $588.6M
YoY Change 8.65% 8.4%
Common Stock $338.8M $335.1M
YoY Change 6.74% 6.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $545.8M $546.2M
YoY Change 6.51% 6.55%
Treasury Stock Shares
Shareholders Equity $393.2M $374.3M
YoY Change
Total Liabilities & Shareholders Equity $709.2M $629.4M
YoY Change 17.36% 11.12%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $29.23M $30.14M
YoY Change 13.51% 3.5%
Depreciation, Depletion And Amortization $2.486M $2.324M
YoY Change 13.72% 16.9%
Cash From Operating Activities $48.34M $10.43M
YoY Change 19.22% -255.63%
INVESTING ACTIVITIES
Capital Expenditures $1.146M $1.482M
YoY Change -78.96% -73.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.146M -$1.482M
YoY Change -78.96% -73.85%
FINANCING ACTIVITIES
Cash Dividend Paid $15.58M
YoY Change 7.47%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.60M -27.23M
YoY Change -0.41% 14.69%
NET CHANGE
Cash From Operating Activities 48.34M 10.43M
Cash From Investing Activities -1.146M -1.482M
Cash From Financing Activities -12.60M -27.23M
Net Change In Cash 34.59M -18.49M
YoY Change 54.13% -48.38%
FREE CASH FLOW
Cash From Operating Activities $48.34M $10.43M
Capital Expenditures $1.146M $1.482M
Free Cash Flow $47.19M $8.950M
YoY Change 34.46% -172.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-29
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000851520
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-29
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-18655
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
EXPONENT, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0218904
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
149 COMMONWEALTH DRIVE
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
MENLO PARK
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
CY2024Q1 dei City Area Code
CityAreaCode
650
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
326-9400
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
EXPO
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50670271
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168665000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187150000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6302000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5281000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
162885000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167360000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20773000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25022000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
352323000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
379532000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
106162000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
104011000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74503000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75318000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24145000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24600000
CY2024Q1 us-gaap Goodwill
Goodwill
8607000
CY2023Q4 us-gaap Goodwill
Goodwill
8607000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
52224000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53824000
CY2024Q1 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
113844000
CY2023Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
101169000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3759000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3727000
CY2024Q1 us-gaap Assets
Assets
629405000
CY2023Q4 us-gaap Assets
Assets
646777000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
23926000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22125000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
68285000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
111773000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16106000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21709000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5814000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6302000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
114131000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
161909000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3580000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3426000
CY2024Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
116005000
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
103398000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21378000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21959000
CY2024Q1 us-gaap Liabilities
Liabilities
255094000
CY2023Q4 us-gaap Liabilities
Liabilities
290692000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
66000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
335014000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
321448000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3187000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2977000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
588570000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
574082000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15033000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15134000
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
546152000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
536534000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
374311000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
356085000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
629405000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
646777000
CY2024Q1 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
137207000
CY2023Q1 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
128705000
CY2024Q1 expo Revenue From Reimbursement
RevenueFromReimbursement
7726000
CY2023Q1 expo Revenue From Reimbursement
RevenueFromReimbursement
11604000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144933000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140309000
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
90327000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
84181000
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10531000
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
9561000
CY2024Q1 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
7726000
CY2023Q1 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
11604000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5636000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5843000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
114220000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
111189000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
30713000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29120000
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2626000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1770000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7084000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4648000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9710000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6418000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
40423000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35538000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10281000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6414000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
30142000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29124000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51006000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51132000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51419000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51682000
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
30142000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29124000
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-210000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
460000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29932000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29584000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
356085000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
518000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4026000
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5466000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-210000
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10846000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6796000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
100000
CY2024Q1 us-gaap Dividends
Dividends
14934000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
30142000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
374311000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
320752000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
580000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4205000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
460000
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10497000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-9920000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
100000
CY2023Q1 us-gaap Dividends
Dividends
13942000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
29124000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
341856000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
30142000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
29124000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2324000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1988000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1279000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
892000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7340000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7063000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1600000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1725000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3196000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3842000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2193000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7777000
CY2024Q1 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
614000
CY2023Q1 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
774000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2577000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2271000
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-29616000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-28564000
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5603000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4267000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10432000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6703000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1482000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5668000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1482000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5668000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6796000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9920000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5466000
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
618000
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
680000
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
15583000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
14500000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27227000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23740000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-208000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18485000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35809000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187150000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161458000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168665000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125649000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51419000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51682000
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100833
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7956000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8566000
CY2024Q1 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
2747000
CY2023Q1 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
5751000
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
183537000
CY2024Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
129139000
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
129139000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
169873000
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
116564000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
116564000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51006000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51132000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14835
CY2024Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
128135000
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
115187000
CY2024Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
129139000
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
116564000
CY2024Q1 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
6267000
CY2023Q1 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
3918000
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1102000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1263000
CY2024Q1 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10846000
CY2023Q1 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10497000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
164000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1210000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1103000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6302000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5281000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
162885000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167360000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5281000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1279000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
258000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6302000
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144933000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140309000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
30713000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29120000
CY2024Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
1509000
CY2023Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
5861000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2324000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1988000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2524000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2364000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4898000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6650000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6031000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4527000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2094000
CY2024Q1 expo Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
8322000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
32522000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5330000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
27192000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 expo Rule10 B51 Arrangement Modified Flag
Rule10B51ArrangementModifiedFlag
false
CY2024Q1 expo Non Rule10 B51 Arrangement Modified Flag
NonRule10B51ArrangementModifiedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-052966-index-headers.html Edgar Link pending
0000950170-24-052966-index.html Edgar Link pending
0000950170-24-052966.txt Edgar Link pending
0000950170-24-052966-xbrl.zip Edgar Link pending
expo-20240329.htm Edgar Link pending
expo-20240329.xsd Edgar Link pending
expo-ex31_1.htm Edgar Link pending
expo-ex31_2.htm Edgar Link pending
expo-ex32_1.htm Edgar Link pending
expo-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
expo-20240329_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending